StockData
Entera Bio Ltd. logo

Entera Bio Ltd. (ENTX) stock

ENTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$3.00−0.02 (-0.66%)

Close on Nov 17, 2026Market cap $519.43MP/E –Yield –

Entera Bio market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Entera Bio's market cap was $158.71M on Nov 11, 2026, against $108.68M a year earlier. Over the last 5 years it ranged from $17.29M to $158.71M, with a median of $62.94M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$158.71M+79.2%
2025Dec 31, 2025$88.59M+14.4%
2024Dec 31, 2024$77.41M+347.7%
2023Dec 29, 2023$17.29M-17.8%
2022Dec 30, 2022$21.03M-73.6%
2021Dec 31, 2021$79.63M+304.3%
2020Dec 31, 2020$19.69M-19.7%
2019Dec 31, 2019$24.52M+79.0%
2018Dec 31, 2018$13.70M–

More Entera Bio figures

See a number that looks wrong?